Novel risk model for predicting incident atrial fibrillation in patients taking ω-3 fatty acid: sub-analysis of the STRENGTH randomized trial

Fish oils are associated with higher risk of incident atrial fibrillation (AF) in randomized trials, risk factors for this remain unknown. We analyzed associated factors and developed a novel risk score for predicting AF in patients at elevated cardiovascular risk in this secondary analysis of the STRENGTH trial. The STRENGTH trial randomized 13,078 patients at high cardiovascular risk at 1:1 ratio to receive either ω-3 carboxylic acid (CA) or corn oil placebo at 675 centers during 10/30/2014-6/14/2017. Multivariable Cox proportional hazards regression was performed to develop a risk score to help identify new AF during follow-up in the ω-3 CA group without prior history of AF. Amongst 6,000 ω-3 CA group and 6,012 placebo group patients without history of AF, 126 (2.1%) and 75 (1.2%) developed AF, respectively, during mean follow-up of 3.5±0.8 years. In the ω-3 CA arm, older age, males, higher body mass index, history of heart failure, insulin-dependent diabetes, and elevated high-sensitivity C-reactive protein were independently associated with incident AF during follow-up. A novel risk score based on these six parameters predicted incident AF with c-index 0.72 in the ω-3 CA group, and 0.73 when applied to the placebo group. A novel risk score for predicting AF development in patients at elevated cardiovascular risk receiving ω-3 CA had moderate discriminative ability in both patients receiving ω-3 CA and placebo. Further research is necessary to externally validate our risk score and determine how it may guide AF management and prevention and improve clinical outcomes. Novel risk score for predicting incident atrial fibrillation in patients at elevated cardiovascular risk receiving ω-3 CA (top left), receiver-operating characteristic curve for predicting incident atrial fibrillation (top right), and atrial fibrillation event rates during follow-up by risk score categories (bottom).

Authors

Institutions

Publication Details

Journal
American Journal of Preventive Cardiology
Published
2026-03-01
DOI
https://doi.org/10.1016/j.ajpc.2026.101583
Primary Topic
Fatty Acid Research and Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel risk model for predicting incident atrial fibrillation in patients taking ω-3 fatty acid: sub-analysis of the STRENGTH randomized trial

Becky Yi-Wen Liao, Tom Kai Ming Wang, Julie St. John, Clement Tan et al.
American Journal of Preventive Cardiology
Fatty Acid Research and Health
article

Novel risk model for predicting incident atrial fibrillation in patients taking ω-3 fatty acid: sub-analysis of the STRENGTH randomized trial

Becky Yi-Wen Liao, Tom Kai Ming Wang, Julie St. John, Clement Tan, Steven E Nissen, Kathy Wolski, Stephen J. Nicholls
article en

Abstract

Fish oils are associated with higher risk of incident atrial fibrillation (AF) in randomized trials, risk factors for this remain unknown. We analyzed associated factors and developed a novel risk score for predicting AF in patients at elevated cardiovascular risk in this secondary analysis of the STRENGTH trial. The STRENGTH trial randomized 13,078 patients at high cardiovascular risk at 1:1 ratio to receive either ω-3 carboxylic acid (CA) or corn oil placebo at 675 centers during 10/30/2014-6/14/2017. Multivariable Cox proportional hazards regression was performed to develop a risk score to help identify new AF during follow-up in the ω-3 CA group without prior history of AF. Amongst 6,000 ω-3 CA group and 6,012 placebo group patients without history of AF, 126 (2.1%) and 75 (1.2%) developed AF, respectively, during mean follow-up of 3.5±0.8 years. In the ω-3 CA arm, older age, males, higher body mass index, history of heart failure, insulin-dependent diabetes, and elevated high-sensitivity C-reactive protein were independently associated with incident AF during follow-up. A novel risk score based on these six parameters predicted incident AF with c-index 0.72 in the ω-3 CA group, and 0.73 when applied to the placebo group. A novel risk score for predicting AF development in patients at elevated cardiovascular risk receiving ω-3 CA had moderate discriminative ability in both patients receiving ω-3 CA and placebo. Further research is necessary to externally validate our risk score and determine how it may guide AF management and prevention and improve clinical outcomes. Novel risk score for predicting incident atrial fibrillation in patients at elevated cardiovascular risk receiving ω-3 CA (top left), receiver-operating characteristic curve for predicting incident atrial fibrillation (top right), and atrial fibrillation event rates during follow-up by risk score categories (bottom).

American Journal of Preventive Cardiology
Cleveland Clinic (US)
Openalex Percentile: Top 6%
Fatty Acid Research and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.